Additional information
White crystalline powder
163380-20-9
ACI-051120
(3R,4S)-3-[(3S)-3-(Acetyloxy)-3-(4-fluorophenyl)propyl]-4-[4-(acetyloxy) phenyl]-1-(4-fluorophenyl)-2-azetidinone
(3R,4S)-3-[(3S)-3-(Acetyloxy)-3-(4-fluorophenyl)propyl]-4-[4-(acetyloxy)phenyl]-1-(4-fluorophenyl)-2-azetidinone
62.9-64.1°C
C28H25F2NO5
493.5
Ambient
2-8°C
4-((2S,3R)-3-((S)-3-acetoxy-3-(4-fluorophenyl)propyl)-1-(4-fluorophenyl)-4-oxoazetidin-2-yl)phenyl acetate
Dyslipidemic agent





![6,9-DIACYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl (2R,2'R,3S,3'S)-bis(3-benzamido-2-hydroxy-3-phenylpropanoate))](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)